Rep. Kuster Statement on FDA Authorization of Pfizer-BioNTech's COVID-19 Vaccine for Children 12 to 15
May 11, 2021
May 11, 2021
CONCORD, New Hampshire, May 11 -- Rep. Ann Kuster, D-New Hampshire, issued the following statement on May 10, 2021:
* * *
Following the Food and Drug Administration's decision to extend the Emergency Use Authorization for Pfizer-BioNTech's COVID-19 vaccine to children 12 to 15, Rep. Annie Kuster (NH-02) released the following statement:
"Reopening our schools, rebuilding our economy, and overcoming the COVID-19 pandemic hinges on our ability to vaccina . . .
* * *
Following the Food and Drug Administration's decision to extend the Emergency Use Authorization for Pfizer-BioNTech's COVID-19 vaccine to children 12 to 15, Rep. Annie Kuster (NH-02) released the following statement:
"Reopening our schools, rebuilding our economy, and overcoming the COVID-19 pandemic hinges on our ability to vaccina . . .